Amalia Velasco

Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.

Laura García‐Estévez, J. Cuevas, Antonio Antón et al. · PubMed · 2003 · 70 citations

Medicine, Oncology, Pharmacology +17

A Phase II Study of Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

Laura García‐Estévez, Norberto Batista, Pedro Sánchez‐Rovira et al. · Clinical Breast Cancer · 2008 · 35 citations

Medicine, Oncology, Pharmacology +14

Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer

Pablo Borrega, Amalia Velasco, Matilde Bolaños et al. · Urologic Oncology Seminars and Original Investigations · 2004 · 18 citations

Medicine, Oncology, Pharmacology +14

Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study

Pedro Sánchez‐Rovira, Antonio Antón, Agustí Barnadas et al. · Clinical & Translational Oncology · 2012 · 14 citations

Medicine, Oncology, Pharmacology +14